pirfenidone has been researched along with colchicine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Lasky, JA; Ortiz, LA | 1 |
| Cottin, V | 1 |
| Rockey, DC | 1 |
| Balduzzi, S; Cerri, S; D'Amico, R; Del Giovane, C; Luppi, F; Richeldi, L; Spagnolo, P; Walters, EH | 1 |
| Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU | 1 |
| Concepción Carrillo, LE; Iturbe Esquivel, B; Mendieta Zeron, H; Meneses Calderón, J | 1 |
5 review(s) available for pirfenidone and colchicine
| Article | Year |
|---|---|
Antifibrotic therapy for the treatment of pulmonary fibrosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Colchicine; Humans; Interferon Type I; Interferon-gamma; Niacin; Penicillamine; Pulmonary Fibrosis; Pyridones; Recombinant Proteins; Taurine | 2001 |
[Treatment of pulmonary fibrosis].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Azathioprine; Colchicine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Lung; Lung Transplantation; Male; Middle Aged; Oxygen Inhalation Therapy; Pregnancy; Prognosis; Prospective Studies; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Time Factors | 2002 |
Current and future anti-fibrotic therapies for chronic liver disease.
Topics: Angiotensin II; Chronic Disease; Colchicine; Collagen; Extracellular Matrix; Hepatic Stellate Cells; Humans; Interferon-gamma; Ligands; Liver Cirrhosis; PPAR gamma; Pyridones | 2008 |
Non-steroid agents for idiopathic pulmonary fibrosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colchicine; Cyclophosphamide; Humans; Immunosuppressive Agents; Interferon-gamma; Prednisone; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Recombinant Proteins | 2010 |
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators | 2013 |
4 other study(ies) available for pirfenidone and colchicine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Notable changes in the 2016 update: citalopram, escitalopram, diclofenac added to the list of drugs to avoid.
Topics: Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Citalopram; Colchicine; Diclofenac; Humans; Hypnotics and Sedatives; Omalizumab; Pyridones; Venlafaxine Hydrochloride | 2016 |
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series.
Topics: Adult; Colchicine; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; SARS-CoV-2 | 2022 |